Deleted in lung and esophageal cancer (DLEC1) is a tumour suppressor that is frequently silenced by promoter methylation in various kinds of cancer [, , ]. However, in head and neck squamous cell carcinoma, DLEC1 is not silenced solely by promoter methylation []. It has been shown to repress NF-kB signalling in prostate cancer [].